Create a comprehensive postgraduate (DM Gastroenterology) PowerPoint presentation on "Eosinophilic Disorders of the Gastrointestinal Tract (EGIDs)" suitable for a departmental seminar, grand rounds, or conference presentation. Presentation Requirements Length: 70–90 slides Audience: DM Gastroenterology residents, Gastroenterologists, Pathologists, Allergists, and Internal Medicine faculty Design: Professional academic theme with white background, blue accents, clean typography, minimal text, high-quality medical illustrations, endoscopic images, histopathology photomicrographs, radiology images, tables, timelines, flowcharts, and infographics. Every slide should include speaker notes with detailed explanations. Include Vancouver-style references at the bottom of each slide. Presentation Outline 1. Title Slide 2. Learning Objectives 3. Introduction Definition of eosinophilic gastrointestinal disorders (EGIDs) Historical evolution Why EGIDs are increasingly recognized Clinical significance 4. Epidemiology Global incidence and prevalence Geographic variations Adult vs pediatric disease Male predominance Indian data (if available) 5. Classification Eosinophilic Esophagitis (EoE) Eosinophilic Gastritis (EoG) Eosinophilic Duodenitis (EoD) Eosinophilic Gastroenteritis (EGE) Eosinophilic Colitis (EC) Eosinophilic Enteritis Non-EGID causes of GI eosinophilia Include an easy-to-understand classification diagram. Normal GI Eosinophils Development of eosinophils Physiology Distribution in different GI segments Normal eosinophil counts Functions in immune homeostasis Include a comparison table of normal eosinophil counts throughout the GI tract. Immunology & Pathogenesis Explain with detailed pathway diagrams: Th2 inflammation IL-4 IL-5 IL-13 Eotaxin-3 TSLP STAT6 signaling IgE-dependent mechanisms Non-IgE mechanisms Barrier dysfunction Epithelial cytokines Genetics CAPN14 Filaggrin abnormalities Microbiome Environmental risk factors Include colorful immunology flowcharts. Organ-wise Disease Eosinophilic Esophagitis Discuss in detail: Epidemiology Clinical presentation Endoscopic findings EREFS classification Histology Diagnostic criteria Differential diagnosis Natural history Fibrostenotic disease Complications Include high-quality endoscopic images. Eosinophilic Gastritis Clinical features Endoscopic findings Histology Diagnostic criteria Differential diagnosis Eosinophilic Duodenitis Presentation Histology Diagnosis Management Eosinophilic Gastroenteritis Explain according to Klein classification: Mucosal disease Muscular disease Serosal disease Include: Clinical features Endoscopy Histopathology CT findings Ultrasound findings Eosinophilic Colitis Clinical features Histopathology Colonoscopy Differential diagnosis Management Diagnostic Approach Create a detailed diagnostic algorithm including: History Physical examination CBC Peripheral eosinophilia Serum IgE Stool examination Parasitic evaluation Endoscopy Biopsy protocol Histopathology Radiology Exclusion of secondary causes Bone marrow examination Molecular studies when indicated Histopathology Include: Microscopic images Normal histology Characteristic findings Eosinophilic microabscesses Basal cell hyperplasia Lamina propria fibrosis Subepithelial fibrosis Degranulation Explain eosinophil count thresholds for each GI segment. Differential Diagnosis Differentiate EGIDs from: Parasitic infections Drug-induced eosinophilia IBD Celiac disease Autoimmune diseases Hypereosinophilic syndrome Vasculitis Malignancy Lymphoma GVHD Systemic eosinophilic disorders Prepare comparison tables. Management Dietary Therapy Elemental diet Six-food elimination diet Four-food elimination diet Targeted elimination Step-up approach Dietitian involvement Pharmacological Therapy Discuss mechanism, dose, evidence and adverse effects of: PPI Swallowed Budesonide Fluticasone Prednisolone Montelukast Azathioprine 6-Mercaptopurine Methotrexate Tacrolimus Cyclosporine Biological Therapy Discuss in detail: Dupilumab Benralizumab Mepolizumab Reslizumab Lirentelimab Cendakimab Emerging anti-IL-13 therapies Emerging anti-Siglec-8 therapies Include mechanism diagrams. Endoscopic Therapy Indications Technique Complications Balloon dilation Bougie dilation Management of strictures Monitoring Clinical remission Histological remission Endoscopic remission Patient-reported outcomes Follow-up intervals Repeat biopsy indications Recent Guidelines (2024–2025) Summarize recommendations from: ACG AGA EAACI UEG International Consensus Create summary tables of recommendation strength and evidence quality. Landmark Clinical Trials Include dedicated slides for: LIBERTY EoE TREET Dupilumab Phase III MESSINA Mepolizumab trials Benralizumab MESSINA trial Lirentelimab ENIGMA give me prompt for my presentation on topic eosinophilic disorders in git for dokie ai Comprehensive Dokie AI Prompt Create a high-quality, postgraduate (DM Gastroenterology) PowerPoint presentation on "Eosinophilic Disorders of the Gastrointestinal Tract (EGIDs)" suitable for a 60–75 minute academic seminar, grand rounds, or conference presentation. General Requirements Audience: DM Gastroenterology residents, gastroenterologists, internists, pathologists, allergists, and medical faculty. Length: 80–100 slides. Style: Professional academic presentation with a clean white background, blue accents, modern typography, minimal text, and visually engaging layouts. Include high-resolution medical illustrations, endoscopic images, histopathology photomicrographs, radiology images, immunology pathway diagrams, clinical algorithms, flowcharts, tables, timelines, and infographics. Every slide should contain detailed speaker notes explaining the concepts. Include key references (Vancouver style) at the bottom of each slide. Base all recommendations on 2025 evidence, citing the latest ACG, AGA, EAACI, ESPGHAN, UEG, and International Consensus guidelines, along with landmark studies published in Gastroenterology, Gut, American Journal of Gastroenterology, Clinical Gastroenterology & Hepatology, Journal of Allergy and Clinical Immunology, and The Lancet. Presentation Outline 1. Title Slide Eosinophilic Disorders of the Gastrointestinal Tract (EGIDs) Presenter name, institution, department 2. Learning Objectives 3. Historical Evolution of EGIDs 4. Definition and Classification EGIDs overview Organ-specific disease classification Primary vs secondary GI eosinophilia 5. Epidemiology Global incidence and prevalence Geographic variation Pediatric vs adult disease Male predominance Indian epidemiology Normal GI Eosinophils Include: Development of eosinophils Normal distribution throughout GI tract Normal eosinophil counts by GI segment Physiological functions Mucosal immunity Create a comprehensive comparison table. Immunology & Pathogenesis Provide detailed illustrations explaining: Th2 immune response IL-4 IL-5 IL-13 IL-33 TSLP Eotaxin-3 (CCL26) STAT6 signaling Siglec-8 pathway Mast cells Basophils Barrier dysfunction CAPN14 Filaggrin Genetic susceptibility Microbiome Environmental risk factors Food allergens Include colorful immunology pathway diagrams. Organ-wise Disorders Eosinophilic Esophagitis (EoE) Cover: Epidemiology Risk factors Clinical features Dysphagia Food impaction Chest pain Pediatric presentation Endoscopic findings EREFS classification Histopathology Diagnostic criteria Differential diagnosis Fibrostenotic disease Natural history Complications Include: Endoscopy images Histology images EREFS scoring table Eosinophilic Gastritis Clinical presentation Histopathology Endoscopy Differential diagnosis Management Eosinophilic Duodenitis Pathology Clinical features Diagnosis Histology Treatment Eosinophilic Gastroenteritis Discuss according to Klein classification: Mucosal disease Muscular disease Serosal disease Include: Clinical manifestations Imaging Endoscopy Histopathology CT findings Ultrasound findings Ascites in serosal disease Eosinophilic Colitis Clinical presentation Colonoscopy Histopathology Differential diagnosis Treatment Secondary Causes of GI Eosinophilia Discuss in detail: Helminth infections Protozoal infections Drug-induced eosinophilia Inflammatory bowel disease Celiac disease Autoimmune disorders Connective tissue disorders Hypereosinophilic syndrome EGPA Vasculitis GVHD HIV Malignancy Lymphoma Mastocytosis Prepare comparison tables. Diagnostic Approach Create a stepwise diagnostic algorithm including: History Clinical examination CBC Absolute eosinophil count Serum IgE Inflammatory markers Stool examination Parasitic evaluation Endoscopy Multiple biopsies Histopathology Immunostaining Radiology CT MRI EUS where appropriate Bone marrow evaluation Molecular testing Exclusion of secondary causes Prepare an evidence-based diagnostic flowchart. Histopathology Include: Normal histology Characteristic microscopic findings Eosinophilic microabscesses Surface layering Degranulation Cryptitis Fibrosis Lamina propria infiltration Subepithelial fibrosis Threshold eosinophil counts for each GI segment Provide labeled pathology images. Differential Diagnosis Compare EGIDs with: GERD Achalasia Crohn's disease Ulcerative colitis Celiac disease Parasitic infections Hypereosinophilic syndrome EGPA Drug-induced disease Lymphoma Carcinoma Prepare high-yield comparison tables. Management Dietary Therapy Explain: Elemental diet Six-food elimination diet Four-food elimination diet Two-food elimination diet One-food elimination diet Targeted elimination Dietitian-guided therapy Response assessment Medical Therapy Explain mechanism, dosage, evidence, adverse effects, and monitoring of: PPI Swallowed Budesonide Fluticasone Prednisolone Montelukast Azathioprine 6-Mercaptopurine Methotrexate Tacrolimus Cyclosporine Biological Therapy Discuss in detail: Dupilumab Cendakimab Benralizumab Mepolizumab Reslizumab Lirentelimab Emerging IL-13 inhibitors Anti-Siglec-8 therapy Future biologics Create mechanism-of-action diagrams. Endoscopic Therapy Balloon dilation Bougie dilation Indications Contraindications Complications Technique Outcome data Monitoring Clinical remission Endoscopic remission Histologic remission Patient-reported outcomes Quality of life Repeat biopsy recommendations Follow-up schedule Recent Guidelines (2024–2025) Summarize: ACG Guideline AGA Clinical Practice Update EAACI Guideline ESPGHAN Pediatric Guideline UEG Recommendations International Consensus Statements Create summary tables with: Recommendation Strength of recommendation Level of evidence Practical clinical takeaway Landmark Clinical Trials Include dedicated slides summarizing: LIBERTY EoE TREET MESSINA Trial Dupilumab Phase III studies Benralizumab trials Mepolizumab trials Lirentelimab ENIGMA studies Cendakimab Phase III studies Other major biologic trials through 2025 For each trial include: Study design Population Intervention Outcomes Strengths Limitations Clinical implications Special Populations Pediatric EGIDs Elderly patients Pregnancy Refractory disease Steroid-dependent disease Fibrostenotic EoE Nutritional deficiencies Overlap with atopic disorders Future Directions Precision medicine Biomarkers AI-assisted endoscopy Digital pathology Molecular phenotyping Non-invasive biomarkers Novel biologics Personalized dietary therapy Clinical Pearls Create a slide with 20–30 high-yield take-home points for postgraduate examinations and clinical practice. Case-Based Learning Include 3–5 real-world clinical cases with: History Endoscopic findings Histology Differential diagnosis Management Key learning points Summary Conclude with: Key messages Clinical algorithm Practice recommendations Future perspectives Final Requirements Include 20+ diagnostic and management algorithms, 25+ comparison tables, and 50+ high-quality figures/illustrations. Ensure all information is evidence-based, guideline-concordant, and updated through 2025. End with 40–60 references from major gastroenterology and allergy journals.

Reading File
Reading File
Searching PubMed

"eosinophilic esophagitis" AND dupilumab

Searching PubMed

"eosinophilic gastrointestinal disorders" AND guidelines

Searching the Web

EoE EGID guidelines 2024 2025 ACG AGA EAACI dupilumab approval landmark trials

Reading File
Finding Sources
Searching PubMed

"eosinophilic gastritis" OR "eosinophilic gastroenteritis" OR "eosinophilic colitis" treatment biologics

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Running Command

mkdir -p /home/daytona/workspace/egid-presentation && ls /home/daytona/workspace…

ppt?

is the ppt ready

This is a shared conversation. Sign in to Orris to start your own chat.